Suchergebnisse - "Wang, Yixin"

PubPharm (8)

1

Combinations of chemo-, immuno-, and gene therapies using nanocarriers as a multifunctional drug platform

enthalten in: Expert opinion on drug delivery | 2022

von Hopkins, C. | Javius-Jones, K. | Wang, Y. | +3

2

Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2020

von Li, Z. | Zhu, L. | Sun, H. | +6

3

Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma

enthalten in: Molecular pharmaceutics | 2015

von Cao, H. | Wang, Y. | He, X. | +9

ErratumIn: Mol Pharm. 2020 Jan 6;17(1):359. - PMID 31802672

4

Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide

enthalten in: International journal of nanomedicine | 2013

von Li, C. | Wang, Y. | Zhang, X. | +3

5

Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer

enthalten in: Clinical chemistry | 2010

von Jiang, Y. | Palma, J. | Agus, D. | +2

CommentIn: Clin Chem. 2010 Sep;56(9):1375-7. - PMID 20675611

6

The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine

enthalten in: Drug discovery today | 2008

von Foekens, J. | Wang, Y. | Martens, J. | +2

7

A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia

enthalten in: Blood | 2008

von Raponi, M. | Lancet, J. | Fan, H. | +14

8

Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2007

von Raponi, M. | Harousseau, J. | Lancet, J. | +6

1
[1]